Form 4: Entrada Therapeutics Insider Sells Shares
Insider Transaction (Form 4)
Mpm Bioventures 2018, L.P. and 2 others reported changes in beneficial ownership of Entrada Therapeutics, Inc. common stock on September 4, 2026.
Summary
- Open-market sale: disposed of 38,500 Common Stock at $7.11 ($273,735) on September 4, 2026; holds 4,106,452 after (Indirect).
- Open-market sale: disposed of 192,500 Common Stock at $7.41 ($1,426,425) on September 8, 2026; holds 3,913,952 after (Indirect).
- Open-market sale: disposed of 28,837 Common Stock at $7.13 ($205,608) on September 9, 2026; holds 3,885,115 after (Indirect).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,905,768 of stock on the open market.
Insider Transactions
Mpm Bioventures 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Common Stock | 38,500 | $7 | $273.7K | 4,106,452 |
| 2026-09-08 | Open-market sale | Common Stock | 192,500 | $7 | $1.4M | 3,913,952 |
| 2026-09-09 | Open-market sale | Common Stock | 28,837 | $7 | $205.6K | 3,885,115 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (38,500 shares) |
| 2026-09-08 | Open-market sale (192,500 shares) |
| 2026-09-09 | Open-market sale (28,837 shares) |
Keywords
insider transaction, Form 4, TRDA, Entrada Therapeutics, Inc., bearish, Mpm Bioventures 2018, L.P., MPM BioVentures 2018 LLC, MPM BioVentures 2018 GP LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.